Wedbush Reaffirms Outperform Rating for Sutro Biopharma (NASDAQ:STRO)
Wedbush restated their outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a report released on Tuesday, RTT News reports. They currently have a $12.00 price objective on the stock. Wedbush also issued estimates for Sutro Biopharma’s Q4 2023 earnings at ($0.76) EPS, FY2023 earnings at ($2.97) EPS, Q1 2024 earnings at […]
More Stories
Guy Gosselin Sells 22,500 Shares of Agnico Eagle Mines Limited (TSE:AEM) Stock
Agnico Eagle Mines Limited (TSE:AEM – Get Free Report) (NYSE:AEM) Senior Officer Guy Gosselin sold 22,500 shares of the stock...
Challenger Energy Group (LON:CEG) Shares Up 9.1% – What’s Next?
Shares of Challenger Energy Group PLC (LON:CEG – Get Free Report) shot up 9.1% during mid-day trading on Friday ....
Sage Capital Advisors llc Raises Stock Holdings in Chevron Co. (NYSE:CVX)
Sage Capital Advisors llc grew its position in Chevron Co. (NYSE:CVX – Free Report) by 1.2% during the fourth quarter,...
Tilia Fiduciary Partners Inc. Purchases 1,608 Shares of Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT)
Tilia Fiduciary Partners Inc. lifted its position in Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT – Free Report) by 10.0% during...
Lowe’s Companies, Inc. (NYSE:LOW) Shares Purchased by Tilia Fiduciary Partners Inc.
Tilia Fiduciary Partners Inc. lifted its stake in Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 2.8% in the fourth...
The Greenbrier Companies, Inc. (NYSE:GBX) to Issue Quarterly Dividend of $0.30
The Greenbrier Companies, Inc. (NYSE:GBX – Get Free Report) declared a quarterly dividend on Friday, January 10th,Wall Street Journal reports....